
Evaluation of the dosing regimens of cefoperazone/sulbactam (2:1) in treatment for Gram-negative bloodstream infection: A Monte Carlo simulation study based on BRICS#br#
Wang Xueting1, Ji Jinru 1, Ying Chaoqun1, Liu Zhiying1, Chen Yunbo1, and Xiao Yonghong1, 2, 3
Chinese Journal of Antibiotics ›› 2024, Vol. 49 ›› Issue (07) : 815-822.
Evaluation of the dosing regimens of cefoperazone/sulbactam (2:1) in treatment for Gram-negative bloodstream infection: A Monte Carlo simulation study based on BRICS#br#
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|